Subsequent Events	9 Months Ended
Dec. 31, 2025
Subsequent Events [Abstract]
Subsequent Events	Note 12. Subsequent Events The Company has evaluated events and transactions for potential recognition or disclosure through March 19, 2026. There are no subsequent events to disclose except for the following: Subscriptions On January 1, 2026, we sold and issued 188,523 Common Shares for an aggregate consideration of approximately $4,766 at a price of $25.28 per Common Share, including Common Shares issued through the Company's distribution reinvestment plan. On February 1, 2026, we sold and issued 51,203 Common Shares for an aggregate consideration of approximately $1,292 at a price of $25.23 per Common Share. The Company received $985 of net proceeds relating to the issuance of Common Shares for subscriptions effective March 1, 2026. Distribution Declaration On January 30, 2026, the Company declared a regular distribution in the amount of $0.1773 per share and a special distribution in the amount of $0.0269 per share for its Common Shares, which are payable to shareholders of record as of January 30, 2026, and will be paid on or about March 2, 2026. On February 27, 2026, the Company declared a regular distribution in the amount of $0.1597 per share and a special distribution in the amount of $0.0194 per share for its Common Shares, which are payable to shareholders of record as of February 27, 2026, and will be paid on or about April 2, 2026. These distributions will be paid in cash or reinvested in additional Common Shares for shareholders participating in the Company’s distribution reinvestment plan. Distribution Reinvestment On January 30. 2026, we issued 21,155 Common Shares pursuant to our distribution reinvestment plan. Extension of Waiver Letter Agreement On March 1, 2026, the Fund and the Adviser entered into a Fee Waiver Letter Agreement, which extends the terms of the prior waiver letter agreement dated July 15, 2025, pursuant to which the Adviser agreed to irrevocably waive, which may be effected by a rebate or otherwise, (i) any base management fee due from the Fund to the Adviser under Section 5(a) of the Agreement and (ii) any incentive fee due from the Fund to the Adviser under Section 5(b) of the Agreement from March 1, 2026 through August 31, 2026.

Subsequent Events

9 Months Ended

Dec. 31, 2025

Note 12. Subsequent Events

The Company has evaluated events and transactions for potential recognition or disclosure through March 19, 2026. There are no subsequent events to disclose except for the following:

Subscriptions

On January 1, 2026, we sold and issued 188,523 Common Shares for an aggregate consideration of approximately $4,766 at a price of $25.28 per Common Share, including Common Shares issued through the Company's distribution reinvestment plan.

On February 1, 2026, we sold and issued 51,203 Common Shares for an aggregate consideration of approximately $1,292 at a price of $25.23 per Common Share.

The Company received $985 of net proceeds relating to the issuance of Common Shares for subscriptions effective March 1, 2026.

Distribution Declaration

On January 30, 2026, the Company declared a regular distribution in the amount of $0.1773 per share and a special distribution in the amount of $0.0269 per share for its Common Shares, which are payable to shareholders of record as of January 30, 2026, and will be paid on or about March 2, 2026.

On February 27, 2026, the Company declared a regular distribution in the amount of $0.1597 per share and a special distribution in the amount of $0.0194 per share for its Common Shares, which are payable to shareholders of record as of February 27, 2026, and will be paid on or about April 2, 2026.

These distributions will be paid in cash or reinvested in additional Common Shares for shareholders participating in the Company’s distribution reinvestment plan.

Distribution Reinvestment

On January 30. 2026, we issued 21,155 Common Shares pursuant to our distribution reinvestment plan.

Extension of Waiver Letter Agreement

On March 1, 2026, the Fund and the Adviser entered into a Fee Waiver Letter Agreement, which extends the terms of the prior waiver letter agreement dated July 15, 2025, pursuant to which the Adviser agreed to irrevocably waive, which may be effected by a rebate or otherwise, (i) any base management fee due from the Fund to the Adviser under Section 5(a) of the Agreement and (ii) any incentive fee due from the Fund to the Adviser under Section 5(b) of the Agreement from March 1, 2026 through August 31, 2026.